This Marijuana Stock Sky-Rocketed 11.5% in July

This Marijuana Stock Sky-Rocketed 11.5% in July

Ahead of quarterly earnings and in anticipation of its planned FDA filing for Epidiolex's approval, shares in GW Pharmaceuticals (NASDAQ: GWPH) jumped 11.5% in July, according to S&P Global Market Intelligence.

GW Pharmaceuticals is at the forefront of research into the use of marijuana-derived cannabinoids as medicine.

IMAGE SOURCE: GETTY IMAGES.

Continue reading

Source: Fool.com